New 2026 board members including Dr. Dan Schwartz bring expertise in vision restoration tech like FDA-approved Light Adjustable Lens for post-cataract customization and OCTA for non-invasive retinal imaging of blood flow in diseases. These innovations enhance precision diagnostics for macular degeneration and retinopathy.
Source: research samsung. Original: https://research.samsung.com/news/Celebrating-Samsung-R-D-Institute-China-Beijing-s-Outstanding-Achievements-at-NTIRE-at-the-CVPR-2026


